This brand name is authorized in Japan
The drug ASPENON contains one active pharmaceutical ingredient (API):
|
1
Aprindine
UNII PB5EKT7Q2V - APRINDINE HYDROCHLORIDE
|
|
Aprindine is a class Ib antiarrhythmic agent. Aprindine acts by blocking sodium voltage channels and disrupting interactions between calmodulin and prosphodiesterase. It is used to treat supraventricular and ventricular arrhythmias. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01BB04 | Aprindine | C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BB Antiarrhythmics, class Ib |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2129004M1026, 2129004M2022 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
